Pfizer/BioNTech finds Covid vaccine safe and effective for children 12 to 15

Studies show vaccine produces robust antibody responses in school-age children, companies say

The Pfizer and BioNTech pharmaceutical partnership announced on Wednesday that their Covid-19 vaccine was safe, effective and produced robust antibody responses in 12-to 15-year old children, paving the way for them to seek US authorisation within the next few weeks and from regulators in other countries swiftly thereafter.

Related: Germany restricts use of AstraZeneca jab to over-60s

Continue reading...

Coronavirus | The Guardian

Comments

Popular posts from this blog

Omicron could overwhelm NHS if it is as virulent as Delta, Neil Ferguson says

Ministers accused of sowing confusion over England’s travel advice

VAT: from Covid tests to child car seats, there are calls to ‘scrap the tax’